Qi Sun
8Patents
2h-index
49Co-inventors
47Inventor score
Filing activity: Jan 11, 2010 → May 9, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8956605B2 | Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 | Human Necessities | 3 | Active |
| US10786551B2 | Use of interleukin-22 in the treatment of fatty liver disease | Human Necessities | 2 | Active |
| US10501421B1 | Substituted benzimidazoles as modulators of Ras signaling | Chemistry; Metallurgy | 1 | Active |
| US11945812B2 | Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US11879015B2 | Antibodies or antigen-binding fragments that bind to OX40 | Chemistry; Metallurgy | 0 | Active |
| US12060367B2 | Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US11625514B2 | Numerical simulation method of pulsed laser paint removal and use thereof | Physics | 0 | Active |
| US11318137B2 | Quinazoline compounds as modulators of Ras signaling | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.